That is essential, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (jeff brown top biotech 2020). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was an advancement nearly nobody saw. But it's going to have profound ramifications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment opportunities in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech stocks). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going greater - angel investor. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mainly informing readers. However that's not the huge concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown 1 biotech. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are many fantastic private business on the verge of hitting the public markets And I have actually been working on a brand-new way for you to invest even prior to these companies go public.
This chance has actually been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to book your spot free of charge.
Emma Walsh here, handling editor of the Journal. Routine Diary readers know that tech isn't our typical beat (genetic sequencer stock jeff brown). And when it comes to tech investing, we leave it to the experts. Luckily, we have numerous such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (last year). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid growth and creating extraordinary opportunities for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. last year. However in spite of what many readers might believe, this is a trend that's just getting started. Even though the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (tech predictions). Losing 2 months of manufacturing and sales actually impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is remarkable. More notably, the hold-ups caused by the pandemic developed a ton of pent-up demand. And that need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown latest prediction. Which's not my only 5G forecast When I've spoken about 5G in the past, I've explained its 3 different stages.
In Stage Two, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be used (exponential tech investor). That's when we start to see applications operating on 5G networks. Consider things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summertime. This begins something of a virtuous cycle: The majority of people don't really care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next crucial innovation I predict in 2021 is CRISPR genetic modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was mostly a niche innovation that wasn't well understood. And throughout that time, there were really only 3 companies operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This whole market is successfully a greenfield chance.
There's room for many companies to exist in this space. second wave. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is necessary since the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced utilizing this innovation. This was among those breakthroughs that almost no one noticed. However it's going to have profound ramifications for treating illness. And, naturally, there will be a lot of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps significantly prior to going greater. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin - united arab emirates. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. tech predictions. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date as of February 2021, however we could not independently validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to pick winning technology stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an outstanding viewpoint on the market. He's constantly on the hunt for brand-new chances, and he shares a lot of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully predicted some of the greatest economic occasions of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right every time, but Jeff Brown's precise forecasts have actually earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study uses a number of research services with a wide range of expertises - first lady.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - brownstone research. On its site, Brownstone states its mission is to provide retail financiers with professional-grade research: "For too long, the finest financial investment research study has actually not been available to specific financiers. It has actually been generally booked for investment banks, hedge funds, personal equity, and high-net-worth customers. united states. The objective of Brownstone Research study is to make that type of proprietary research study available to any investors aiming to get an edge in the markets. The goal is easy to deliver special and lucrative financial investment research found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also works as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the marketplace, you understand that he has a track record as a King Midas of sorts. future report review. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. jeff brown market predictions. could be "the most significant trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two advanced technologies: synthetic intelligence and electric automobiles. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automotive market's Holy Grail. As you understand, electric automobiles and self-driving vehicle stocks have actually been big this year, however the Wall Street device has actually been huge on buzz without much concrete result. Despite an extreme increase in competitors over the previous few years, Brown still believes Musk has the very best chance of putting it all together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transportation. Basically, this technology would permit you to rent your cars and truck as a self-governing, self-driving taxi when you're not using it. You just leave the vehicle and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the earnings. It sounds crazy, but it could be closed than you believe.